Diagnostic accuracy of MRI and PET/CT for neck staging prior to salvage total laryngectomy

Jonas Galli, R. Giger, O. Eliçin, Martin Wartenberg, L. Anschuetz, L. Nisa
{"title":"Diagnostic accuracy of MRI and PET/CT for neck staging prior to salvage total laryngectomy","authors":"Jonas Galli, R. Giger, O. Eliçin, Martin Wartenberg, L. Anschuetz, L. Nisa","doi":"10.20517/2394-4722.2022.19","DOIUrl":null,"url":null,"abstract":"Aim: Lymph node (LN) metastases are associated with poor outcomes in patients with recurrent larynx squamous cell carcinoma (LSCC). Neck dissection (ND) is therefore commonly performed along with salvage total laryngectomy (STL). Here, we assess the rate of occult LN metastases and the diagnostic value of MRI and PET/CT for detecting them in recurrent LSCC. Methods: This retrospective study included patients with recurrent LSCC after primary (chemo)radiotherapy [(C)RT] who were re-staged by MRI and/or PET/CT and treated with STL and ND between 2004 and 2019. The histopathology of ND samples was used as the reference standard. Results: Forty-one patients were included. The prevalence of occult metastases in MRI-negative and PET/CT-negative neck nodes was between 3.2% and 6.1%. Negative predictive values of neck node re-staging were 93.9% for MRI, 96.8% for PET/CT, and 96.2% for MRI and PET/CT combined. Conclusion: Both MRI and PET/CT afforded good negative predictive values for nodal staging in patients with recurrent LSCC after (C)RT prior to STL. In selected patients, these radiological modalities, particularly PET/CT, could help to avoid unnecessary surgery to the neck and its associated morbidity.","PeriodicalId":15167,"journal":{"name":"Journal of Cancer Metastasis and Treatment","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Metastasis and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20517/2394-4722.2022.19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: Lymph node (LN) metastases are associated with poor outcomes in patients with recurrent larynx squamous cell carcinoma (LSCC). Neck dissection (ND) is therefore commonly performed along with salvage total laryngectomy (STL). Here, we assess the rate of occult LN metastases and the diagnostic value of MRI and PET/CT for detecting them in recurrent LSCC. Methods: This retrospective study included patients with recurrent LSCC after primary (chemo)radiotherapy [(C)RT] who were re-staged by MRI and/or PET/CT and treated with STL and ND between 2004 and 2019. The histopathology of ND samples was used as the reference standard. Results: Forty-one patients were included. The prevalence of occult metastases in MRI-negative and PET/CT-negative neck nodes was between 3.2% and 6.1%. Negative predictive values of neck node re-staging were 93.9% for MRI, 96.8% for PET/CT, and 96.2% for MRI and PET/CT combined. Conclusion: Both MRI and PET/CT afforded good negative predictive values for nodal staging in patients with recurrent LSCC after (C)RT prior to STL. In selected patients, these radiological modalities, particularly PET/CT, could help to avoid unnecessary surgery to the neck and its associated morbidity.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
补救性全喉切除术前MRI和PET/CT对颈部分期的诊断准确性
目的:淋巴结(LN)转移与复发性喉鳞状细胞癌(LSCC)患者预后不良相关。因此,颈部解剖(ND)通常与挽救性全喉切除术(STL)一起进行。在这里,我们评估隐匿性淋巴结转移率以及MRI和PET/CT在复发性LSCC中的诊断价值。方法:本回顾性研究纳入2004年至2019年期间经MRI和/或PET/CT重新分期并接受STL和ND治疗的原发性(化疗)放疗[(C)RT]复发性LSCC患者。以ND标本的组织病理学作为参考标准。结果:纳入41例患者。在mri阴性和PET/ ct阴性的颈部淋巴结中,隐匿性转移的患病率在3.2%至6.1%之间。颈结再分期MRI阴性预测值为93.9%,PET/CT阴性预测值为96.8%,MRI与PET/CT联合阴性预测值为96.2%。结论:MRI和PET/CT对复发性LSCC患者在(C)RT后进行STL前的淋巴结分期具有良好的阴性预测价值。在选定的患者中,这些放射方式,特别是PET/CT,可以帮助避免不必要的颈部手术及其相关的发病率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.20
自引率
5.30%
发文量
460
期刊最新文献
Research progress of intestinal microbiota in targeted therapy and immunotherapy of colorectal cancer Editorial on “Chinese expert consensus on the clinical practice of non-small cell lung cancer fusion gene detection based on RNA-based NGS” (2023 edition) Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections Mechanical force-mediated interactions between cancer cells and fibroblasts and their role in the progression of hepatocellular carcinoma Fast-tracking drug development with biomarkers and companion diagnostics
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1